Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Feb:113:56-69.
doi: 10.1016/j.pneurobio.2013.07.006. Epub 2013 Aug 16.

Levels and actions of progesterone and its metabolites in the nervous system during physiological and pathological conditions

Affiliations
Review

Levels and actions of progesterone and its metabolites in the nervous system during physiological and pathological conditions

Roberto Cosimo Melcangi et al. Prog Neurobiol. 2014 Feb.

Abstract

Progesterone is synthesized and actively metabolized in the central and peripheral nervous system, into neuroactive steroid metabolites, such as dihydroprogesterone, allopregnanolone and isopregnanolone. Progesterone and/or its metabolites exert a variety of effects acting as physiological regulators of neuronal and glial development and plasticity, controlling reproduction, neuroendocrine events, mood and affection. In addition, these neuroactive steroids maintain neural homeostasis and exert neuroprotective actions. In agreement, metabolic pathways of progesterone are affected by modifications in the level of gonadal hormones and by pathology or injury with a regional specificity and in a sex-dimorphic way. Therefore, observations here summarized may provide a background to design sex-specific therapies based on progesterone metabolites. On this point of view, considering that one of the major limits of a therapy based on neuroactive steroids could be modifications in their plasma levels and their consequent peripheral effects, pharmacological treatments aimed to increase their levels in the nervous system could provide an interesting therapeutic option.

Keywords: 3α,5α-tetrahydroprogesterone; 3α-HSOR; 3α-THP; 3α-hydroxysteroid oxidoreductase; 3β,5α-tetrahydroprogesterone; 3β-HSD; 3β-HSOR; 3β-THP; 3β-hydroxysteroid dehydrogenase; 3β-hydroxysteroid oxidoreductase; 5α-R; 5α-reductase; Allopregnanolone; CNS; DHP; EAE; Gonadectomy; Iba1; LC-MS/MS; LXR; MBP; Metabolism; Neuroactive steroids; Neurodegeneration; Neuroprotection; P0; P450 side-chain cleavage enzyme; P450scc; PMP22; PNS; PR; PREG; PROG; STZ; StAR; TSPO; WT; central nervous system; dihydroprogesterone; experimental autoimmune encephalomyelitis; glycoprotein zero; ionized calcium-binding adapter molecule 1; liquid chromatography tandem mass spectrometry; liver X receptor; myelin basic protein; peripheral myelin protein 22; peripheral nervous system; pregnenolone; progesterone; progesterone receptor; steroidogenic acute regulatory protein; streptozotocin; translocator protein of 18 kDa; wild type.

PubMed Disclaimer

Similar articles

Cited by

Publication types